Completed NA INTERVENTIONAL 2-arm NCT01246947

Tricuspid Annuloplasty for Moderate Tricuspid Regurgitation Associated With Miral Operation

A Prospective Randomized Trial of Tricuspid Annuloplasty for Moderate Tricuspid Regurgitation Associated With Mitral Operation

Sponsor: Edwards Lifesciences

Conditions Cardiac Surgery Tricuspid Valve Regurgitation

Interventions Mitral surgery alone Tricuspid valve repair

Updated 9 times since 2017 Last updated: May 4, 2023 Started: Sep 30, 2010 Primary completion: Jun 30, 2016 Completion: Feb 28, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Cardiac Surgery and Tricuspid Valve Regurgitation and is currently completed. Edwards Lifesciences leads this study, which shows 9 recorded versions since 2010 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jun 2023 — Jul 2024 [monthly]

Completed NA
Mar 2022 — Jun 2023 [monthly]

Completed NA
Jan 2021 — Mar 2022 [monthly]

Completed NA

▶ Show 4 earlier versions

Sep 2019 — Jan 2021 [monthly]

Completed NA
Jun 2018 — Sep 2019 [monthly]

Completed NA
Aug 2017 — Jun 2018 [monthly]

Completed NA

Status: Unknown Status → Completed
Jan 2017 — Aug 2017 [monthly]

Unknown Status NA

First recorded

Sep 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Edwards Lifesciences
University of Maryland, Baltimore

Data source: University of Maryland, Baltimore

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States